PURE Biosciences Inc (OTCQB:PURE)

Data as of 3:58pm ET
 -0.0099 / -1.39%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

PURE Bioscience, Inc. is engaged in the discovery, development and commercialization of bioscience products that provide solutions to global health challenges. Its technology platform is based on stabilized ionic silver and its products include PURE, Axen 30, Silverion and Axenohl, which contain silver dihydrogen citrate. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

Contact Information

PURE Bioscience, Inc.
1725 Gillespie Way
El Cajon California 92020-1098
P:(619) 596-8600
Investor Relations:



Mutual fund holders2.04%
Individual stakeholders17.87%
Other institutional0.00%

Top Executives

Henry R. LambertChief Executive Officer & Director
Peter C. WulffSecretary, Chief Operating & Financial Officer
Bridget TinsleyVice President-Market Development
Tom MyersExecutive VP-Marketing & Product Development
Cliff WechslerExecutive Vice President-Sales

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.